Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Prepaid Assets (2016 - 2025)

Cytokinetics (CYTK) has disclosed Prepaid Assets for 16 consecutive years, with $17.0 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets changed N/A to $17.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $17.0 million for FY2025, N/A changed from the prior year.
  • Prepaid Assets for Q4 2025 was $17.0 million at Cytokinetics, up from $13.0 million in the prior quarter.
  • The five-year high for Prepaid Assets was $20.0 million in Q2 2025, with the low at $3.0 million in Q1 2021.
  • Average Prepaid Assets over 5 years is $13.8 million, with a median of $14.3 million recorded in 2022.
  • The sharpest move saw Prepaid Assets surged 423.44% in 2021, then plummeted 66.13% in 2024.
  • Over 5 years, Prepaid Assets stood at $12.2 million in 2021, then rose by 2.02% to $12.5 million in 2022, then dropped by 4.16% to $11.9 million in 2023, then tumbled by 44.2% to $6.7 million in 2024, then soared by 154.91% to $17.0 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $17.0 million, $13.0 million, and $20.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.